Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Racial, Ethnic and Socioeconomic Diversity and Outcomes of Patients with Graft-versus-Host Disease: A CIBMTR Analysis.
Farhadfar N, Rashid N, Chen K, DeVos JD, Wang T, Ballen KK, Beitinjaneh A, Bhatt VR, Hamilton BK, Hematti P, Gadalla SM, Solomon SR, El Jurdi N, Lee CJ, MacMillan ML, Rangarajan HG, Schoemans HM, Sharma A, Spellman SR, Wingard JR, Lee SJ. Farhadfar N, et al. Among authors: el jurdi n. Blood Adv. 2024 May 22:bloodadvances.2024013074. doi: 10.1182/bloodadvances.2024013074. Online ahead of print. Blood Adv. 2024. PMID: 38776400
Amphiregulin, ST2,and REG3α Biomarker Risk Algorithms as Predictors of Non-Relapse Mortality in Patients with Acute GVHD.
Etra AM, El Jurdi N, Katsivelos N, Kwon D, Gergoudis SC, Morales G, Spyrou N, Kowalyk S, Aguayo-Hiraldo P, Akahoshi Y, Ayuk FA, Baez J, Betts BC, Chanswangphuwana C, Chen YB, Choe HK, DeFilipp Z, Gleich S, Hexner EO, Hogan WJ, Holler E Prof Dr med, Kitko CL, Kraus S, Al Malki MM, MacMillan ML, Pawarode A, Quagliarella F, Qayed M, Reshef R, Schechter-Finkelstein T, Vasova I, Weisdorf DJ, Wölfl M, Young R, Nakamura R, Ferrara JLM, Levine JE, Holtan SG. Etra AM, et al. Among authors: el jurdi n. Blood Adv. 2024 Apr 19:bloodadvances.2023011049. doi: 10.1182/bloodadvances.2023011049. Online ahead of print. Blood Adv. 2024. PMID: 38640195
The best GVHD prophylaxis: Or at least progress towards finding it.
Weisdorf D, El Jurdi N, Holtan SG. Weisdorf D, et al. Among authors: el jurdi n. Best Pract Res Clin Haematol. 2023 Dec;36(4):101520. doi: 10.1016/j.beha.2023.101520. Epub 2023 Oct 20. Best Pract Res Clin Haematol. 2023. PMID: 38092477 Review.
Amphiregulin as a biomarker for monitoring lifethreatening acute graft-versus-host disease: secondary analysis of two prospective clinical trials.
Holtan SG, El Jurdi N, Rashidi A, Betts BC, Demorest C, Galvin JP, MacMillan ML, Weisdorf DJ, Panoskaltsis-Mortari A, Pratta MA. Holtan SG, et al. Among authors: el jurdi n. Haematologica. 2024 May 1;109(5):1557-1561. doi: 10.3324/haematol.2023.283215. Haematologica. 2024. PMID: 37706330 Free PMC article. No abstract available.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Bolaños-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, DiFronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG; BMT CTN 1703 Investigators. Bolaños-Meade J, et al. Among authors: el jurdi n. N Engl J Med. 2023 Jun 22;388(25):2338-2348. doi: 10.1056/NEJMoa2215943. N Engl J Med. 2023. PMID: 37342922 Free PMC article. Clinical Trial.
48 results